Identification and Characterization of Two CRISPR/Cas Systems Associated with the Mosquito Microbiome

Overview

Journal Access Microbiol

Specialty Microbiology

Date 2023 Sep 11

PMID 37691844

Authors

Shivanand Hegde

Hallie E Rauch

Grant L Hughes

Nikki Shariat

Affiliations

Soon will be listed here.

Abstract

The microbiome profoundly influences many traits in medically relevant vectors such as mosquitoes, and a greater functional understanding of host-microbe interactions may be exploited for novel microbial-based approaches to control mosquito-borne disease. Here, we characterized two novel clustered regularly interspaced short palindromic repeats (CRISPR)/Cas systems in sp. Ag1, which was isolated from the gut of an mosquito. Two distinct CRISPR/Cas systems were identified in Ag1, CRISPR1 and CRISPR2. Based on gene composition, CRISPR1 is classified as a type I-E CRISPR/Cas system and has a single array, CRISPR1. CRISPR2 is a type I-F system with two arrays, CRISPR2.1 and CRISPR2.2. RT-PCR analyses show that all genes from both systems are expressed during logarithmic growth in culture media. The direct repeat sequences of CRISPRs 2.1 and 2.2 are identical and found in the arrays of other spp., including and , whereas CRISPR1 is not. We searched for potential spacer targets and revealed an interesting difference between the two systems: only 9 % of CRISPR1 (type I-E) targets are in phage sequences and 91 % are in plasmid sequences. Conversely, ~66 % of CRISPR2 (type I-F) targets are found within phage genomes. Our results highlight the presence of CRISPR loci in gut-associated bacteria of mosquitoes and indicate interplay between symbionts and invasive mobile genetic elements over evolutionary time.

References

Hille F, Charpentier E . CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci. 2016; 371(1707). PMC: 5052741. DOI: 10.1098/rstb.2015.0496. View

Xue C, Sashital D . Mechanisms of Type I-E and I-F CRISPR-Cas Systems in . EcoSal Plus. 2019; 8(2). PMC: 6368399. DOI: 10.1128/ecosalplus.ESP-0008-2018. View

Grissa I, Vergnaud G, Pourcel C . The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics. 2007; 8:172. PMC: 1892036. DOI: 10.1186/1471-2105-8-172. View

Srinivasan V, Rajamohan G . Genome analysis of urease positive Serratia marcescens, co-producing SRT-2 and AAC(6')-Ic with multidrug efflux pumps for antimicrobial resistance. Genomics. 2018; 111(4):653-660. DOI: 10.1016/j.ygeno.2018.04.001. View

Makarova K, Wolf Y, Alkhnbashi O, Costa F, Shah S, Saunders S . An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 2015; 13(11):722-36. PMC: 5426118. DOI: 10.1038/nrmicro3569. View

Cansado-Utrilla C, Zhao S, McCall P, Coon K, Hughes G . The microbiome and mosquito vectorial capacity: rich potential for discovery and translation. Microbiome. 2021; 9(1):111. PMC: 8132434. DOI: 10.1186/s40168-021-01073-2. View

Shariat N, Dudley E . CRISPRs: molecular signatures used for pathogen subtyping. Appl Environ Microbiol. 2013; 80(2):430-9. PMC: 3911090. DOI: 10.1128/AEM.02790-13. View

Medina-Aparicio L, Davila S, Rebollar-Flores J, Calva E, Hernandez-Lucas I . The CRISPR-Cas system in Enterobacteriaceae. Pathog Dis. 2018; 76(1). DOI: 10.1093/femspd/fty002. View

Swarts D, Mosterd C, van Passel M, Brouns S . CRISPR interference directs strand specific spacer acquisition. PLoS One. 2012; 7(4):e35888. PMC: 3338789. DOI: 10.1371/journal.pone.0035888. View

10.

Deveau H, Garneau J, Moineau S . CRISPR/Cas system and its role in phage-bacteria interactions. Annu Rev Microbiol. 2010; 64:475-93. DOI: 10.1146/annurev.micro.112408.134123. View

11.

Hidalgo-Cantabrana C, Sanozky-Dawes R, Barrangou R . Insights into the Human Virome Using CRISPR Spacers from Microbiomes. Viruses. 2018; 10(9). PMC: 6165519. DOI: 10.3390/v10090479. View

12.

Majsec K, Bolt E, Ivancic-Bace I . Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS. BMC Microbiol. 2016; 16:28. PMC: 4782391. DOI: 10.1186/s12866-016-0643-5. View

13.

Toyomane K, Yokota R, Watanabe K, Akutsu T, Asahi A, Kubota S . Evaluation of CRISPR Diversity in the Human Skin Microbiome for Personal Identification. mSystems. 2021; 6(1). PMC: 7857535. DOI: 10.1128/mSystems.01255-20. View

14.

Hidalgo-Cantabrana C, Crawley A, Sanchez B, Barrangou R . Characterization and Exploitation of CRISPR Loci in . Front Microbiol. 2017; 8:1851. PMC: 5626976. DOI: 10.3389/fmicb.2017.01851. View

15.

Liu Z, Dong H, Cui Y, Cong L, Zhang D . Application of different types of CRISPR/Cas-based systems in bacteria. Microb Cell Fact. 2020; 19(1):172. PMC: 7470686. DOI: 10.1186/s12934-020-01431-z. View

16.

Vicente C, Nascimento F, Barbosa P, Ke H, Tsai I, Hirao T . Evidence for an Opportunistic and Endophytic Lifestyle of the Bursaphelenchus xylophilus-Associated Bacteria Serratia marcescens PWN146 Isolated from Wilting Pinus pinaster. Microb Ecol. 2016; 72(3):669-81. DOI: 10.1007/s00248-016-0820-y. View

17.

Pei D, Hill-Clemons C, Carissimo G, Yu W, Vernick K, Xu J . Draft Genome Sequences of Two Strains of Serratia spp. from the Midgut of the Malaria Mosquito Anopheles gambiae. Genome Announc. 2015; 3(2). PMC: 4357753. DOI: 10.1128/genomeA.00090-15. View

18.

Scrascia M, DAddabbo P, Roberto R, Porcelli F, Oliva M, Calia C . Characterization of CRISPR-Cas Systems in Isolated from (Olivier, 1790) (Coleoptera: Curculionidae). Microorganisms. 2019; 7(9). PMC: 6780938. DOI: 10.3390/microorganisms7090368. View

19.

Tikhe C, Dimopoulos G . Phage Therapy for Mosquito Larval Control: a Proof-of-Principle Study. mBio. 2022; 13(6):e0301722. PMC: 9765668. DOI: 10.1128/mbio.03017-22. View

20.

Shi C, Liu Y, Hu X, Xiong J, Zhang B, Yuan Z . A metagenomic survey of viral abundance and diversity in mosquitoes from Hubei province. PLoS One. 2015; 10(6):e0129845. PMC: 4452694. DOI: 10.1371/journal.pone.0129845. View